PRINCETON, N.J., March 5 /PRNewswire-FirstCall/ -- Novo Nordisk, a healthcare company with an 85-year history of innovation and achievement in diabetes care, today announced plans to expand its U.S. headquarters in Princeton to accommodate future growth. In the past five years, the company has experienced a 150 percent increase in employees at its U.S. headquarters.
The new building will have the capacity for more than 400 employees and feature an in-house training facility capable of training 100 employees simultaneously.
"Diabetes in the U.S. is an unfortunate and growing epidemic and we've had to expand to meet that challenge," said Jerzy Gruhn, president of Novo Nordisk, Inc. "The expansion of our headquarters will provide our team of talented and dedicated employees a modern, spacious facility that will enable them to continue changing diabetes and realize our vision of defeating the disease.
"We consider the state of New Jersey and our local community key contributors to our vision, as they have been exemplary partners and have supported and encouraged Novo Nordisk's growth in the area."
"New Jersey has long been a leader in the global healthcare marketplace," said Governor Jon S. Corzine. "Our prime location, robust workforce and high quality of life have been contributing factors to attracting some of the world's major pharmaceutical companies to the state. We are indeed pleased that Novo Nordisk will continue its commitment here by extending its leadership in diabetes care with a larger presence in New Jersey."
In keeping with the company's Triple Bottom Line philosophy of economic
vitality and social and environmental responsibility, the $20-million
facility is expected to acquire Leadership in Energy and Environmental
Design (LEED) certification through a unique, sustainable design. The LEED
Green Building Rating System(TM) is the nationally accepted benchmark for
the design, construction, and operation of high pe
|SOURCE Novo Nordisk|
Copyright©2008 PR Newswire.
All rights reserved